BioHarvest Sciences Inc. (BHST) stock
BHSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.22−0.16 (-11.59%)
Close on Nov 17, 2026Market cap $27.65MP/E –Yield –
BioHarvest Sciences operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was -$7.23M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$7.23M | – |
| FY2024 | Dec 31, 2024 | -$6.68M | – |
| FY2023 | Dec 31, 2023 | -$8.52M | – |
See a number that looks wrong?